Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
855 3 |
Ultima descărcare din IBN: 2021-03-22 22:54 |
SM ISO690:2012 COBEŢ, Valeriu. Lisinopril: eligibilitate terapeutică şi efecte comparative
. In: Curierul Medical, 2010, nr. 2(314), pp. 67-70. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | |||||
Numărul 2(314) / 2010 / ISSN 1875-0666 | |||||
|
|||||
Pag. 67-70 | |||||
|
|||||
Descarcă PDF | |||||
Rezumat | |||||
Lisinopril: Therapeutic Eligibility and Comparative Effects
This article presents some authentic evidences of the Lisinopril effects obtained in diverse clinic trials and prospective studies concerning arterial
hypertension and heart failure treatment. Likewise a lot of characteristic neuroendocrine modulator effects of the Lisinopril are emphasized as well
as its approved therapeutic advantages in comparison to other drugs of the angiotensin converting enzyme inhibitors class, and to angiotensin II
receptor (AT1) antagonists. Through diurnal monitoring of the blood pressure and through prolonged administration, optimal results of Lisinopril
were seen in regard to the indices of the heart failure mortality and of the myocardium remodeling in acute myocardial infarction. This article
summarizes the main pleiotopic effects of Lisinopril which are opportune in the pathogenetic correction of the cardiovascular disorders.
|
|||||
Cuvinte-cheie Lisinopril, cardiovascular agents |
|||||
|